NCT04112940

Brief Summary

This study is part of a larger grant, for which the overall goal is to collect measurements of liquid flow through the oropharynx (i.e., mouth and throat) during swallowing. The focus of this study is to evaluate the flow of liquids of varying consistency in the head and neck cancer population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2016

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

September 27, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 2, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

July 13, 2022

Completed
Last Updated

April 7, 2023

Status Verified

April 1, 2023

Enrollment Period

3 years

First QC Date

September 27, 2019

Results QC Date

June 14, 2022

Last Update Submit

April 5, 2023

Conditions

Keywords

Swallowing

Outcome Measures

Primary Outcomes (2)

  • Number of Participants With Unsafe Swallowing

    Swallowing safety was measured using the Penetration-Aspiration Scale, an 8-point categorical scale which captures the depth to which any material enters the airway and whether or not the material is ejected. Levels 1 and 2 on the scale are considered safe, while levels \> 2 are considered unsafe. Actual scale scores (1-8) will be recorded and then converted to binary categorical scores (\< 3 vs \>/= 3). We will report the frequency (count) of participants showing scores \> 2 by bolus consistency.

    Baseline (single timepoint only)

  • Amount of Residue in the Pharynx

    Residue is material remaining behind in the pharynx after the swallow. We measured residue by tracing the area of barium visible on a lateral view x-ray (in pixels, using ImageJ software) and dividing that area by the squared length C2-C4 cervical spine. This cervical spine scalar provides a common anatomical reference that is a proxy for pharyngeal size, and enables the comparison of residue severity across different people with different neck length and pharynx size. In healthy swallowing, residue is expected to be minimal. We report mean values and standard deviations for amount of residue by consistency (thin, slightly thick, and mildly thick liquids).

    Baseline (single timepoint only)

Secondary Outcomes (1)

  • Number of Participants Reporting Dislike of Thickened Liquid Stimuli

    Baseline (single timepoint only)

Study Arms (1)

Adults with oropharyngeal cancer

Adult participants who have completed radiation therapy for oropharyngeal cancer within the past 3 months will undergo a swallowing x-ray study in which they will swallow up to 15 liquid stimuli prepared to different consistencies using starch and gum based thickeners.

Other: Starch-based Thickened LiquidsOther: Xanthan-gum Thickened Liquids

Interventions

Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.

Also known as: Nestle Resource ThickenUp
Adults with oropharyngeal cancer

Barium will be thickened to slightly, mildly, moderately and extremely thick consistences as defined by the International Dysphagia Diet Standardisation Initiative flow test.

Also known as: Nestle Resource ThickenUp Clear
Adults with oropharyngeal cancer

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults who have recently completed radiation treatment for oropharynx cancer at the University Health Network, Toronto.

You may qualify if:

  • An initial cancer diagnosis of cancer in the base of tongue region of the oropharynx (Tumor staging T2,T3 \& T4; Nodal staging N0 orN1; Human Papilloma Virus + or -).
  • Completion of bilateral radiation therapy to the neck 3 months prior to enrollment
  • No longer requiring primary enteral feeding for nutrition.

You may not qualify if:

  • Prior history of swallowing, motor speech, gastro#esophageal difficulties, chronic sinusitis or taste disturbance.
  • Previous radiation to the head and neck (prior to current illness);
  • Previous cancer diagnosis;
  • Prior or planned neck dissection;
  • Trachestomy in situ;
  • Neurological difficulties unrelated to spinal disorder (e.g. Stroke, Parkinson disease, etc).
  • Cognitive communication difficulties that may hinder ability to participate.
  • Current use of mechanical ventilation
  • Type 1 Diabetes (due to the requirement to swallow stimuli containing starch based thickeners, which carry a significant carbohydrate load).
  • Known allergies to latex, food coloring or dental glue (due to the probability that these items will come into contact with the oral mucosa during data collection).
  • Occupational exposure to radiation exceeding 10 mSv in the past 6 months.
  • Current pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health Network

Toronto, Ontario, M5G 2C4, Canada

Location

MeSH Terms

Conditions

Deglutition DisordersOropharyngeal Neoplasms

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsStomatognathic Diseases

Results Point of Contact

Title
Director, Swallowing Rehabilitation Research Laboratory
Organization
University Health Network

Study Officials

  • Catriona Steele, PhD

    KITE - Toronto Rehabilitation Institute, University Health Network

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2019

First Posted

October 2, 2019

Study Start

December 19, 2016

Primary Completion

December 31, 2019

Study Completion

March 30, 2021

Last Updated

April 7, 2023

Results First Posted

July 13, 2022

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

No plan at this time.

Locations